  See all
 |
Articles: Leukemia/Lymphoma |
Prior Articles
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma
Leukemia and Lymphoma, 11/04/09
Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment
Leukemia and Lymphoma, 11/04/09 Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma
Leukemia and Lymphoma, 11/04/09 Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia
British Journal of Haematology, 11/04/09 Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma
Leukemia and Lymphoma, 11/04/09 Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993
British Journal of Haematology, 11/04/09 Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
Annals of Oncology, 11/04/09 Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes
Leukemia and Lymphoma, 11/04/09 Successful Treatment of Hepatic Encephalopathy in a Patient with Acute Lymphoblastic Leukemia
Acta Haematologica, 11/04/09 Treatment-Related Burkitt's Lymphoma: Literature Review and Case Report of Successful Treatment with Rituximab Monotherapy
Acta Haematologica, 11/04/09 BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients
European Journal of Haematology, 11/04/09 Bone and [ 18 F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults
Leukemia and Lymphoma, 11/04/09 Age-related EBV-associated B-cell lymphoproliferative disorders: Diagnostic approach to a newly recognized clinicopathological entity
Pathology International, 11/04/09
Revew Article
Interim 18 F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation - where do we stand
Leukemia and Lymphoma, 11/04/09 Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells
Cancer Chemotherapy and Pharmacology, 11/04/09 Early detection of patients with poor risk diffuse large B-cell lymphoma
Leukemia and Lymphoma, 11/04/09 Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments
Leukemia and Lymphoma, 11/04/09 Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas
Leukemia and Lymphoma, 11/04/09 Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation
Leukemia and Lymphoma, 11/04/09 Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas - the PETAL trial
Leukemia and Lymphoma, 11/04/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
